Lankford Questions FDA Changes to Abortion Drug Use

Senator James Lankford demands information from the Food and Drug Administration about possible changes to the way a certain abortion drug is handled.

Lankford, joined by Congressman Chris Smith, sent a letter to the FDA requesting information about the agency’s recent decision to change policies regarding the abortion drug, mifepristone also known as RU-486.

The FDA has loosened the standards of use of mifepristone. Several side effects have been reported in association with the drug, including hemorrhaging, severe infections, and death. However, the data on Adverse Events due to the drug have not been updated since April 2011. Lankford’s letter demands the updated figures on adverse effects of the drug and other information.

The letter requests a response from the FDA by May 20, 2016.


Print pagePDF pageEmail page
  1. Mark Irwin, 26 April, 2016

    Folks, we have seen plows like this for over forty years from the “pro life” Republicans” to end abortion and who never seem to get it done. The money is in fighting the fight, winning a battle here or there, but never winning the war because that would dry up the money pool. Ask yourself why didn’t the pro life, conservative Republicans remove this issue from the jurisdiction of the Federal Courts when they controlled both houses of congress and the white house–if they really wanted to win the war?

*

Copyright © The McCarville Report